The Liquid Biopsy Market is positioned at a critical juncture where analytical technology maturation, clinical evidence accumulation, and healthcare delivery transformation are converging to create sustained demand for non-invasive molecular profiling across the cancer care continuum. The practice of oncology has been fundamentally reshaped by precision medicine, with molecular biomarkers now...